Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a long-lasting high-risk HPV infection that has continued for at least 6 months after treatment for a cervical or vaginal problem, OR you have had a return of a serious pre-cancerous condition or cancer in the cervix or vagina.
- You have given your written agreement to take part in the study.
- You are covered by a social security or health insurance scheme (this appears to be a French/European requirement — confirm with trial site).
Who may not be able to join:
- Your HPV infection or related condition is linked only to a "low-risk" type of HPV (meaning a type that is less likely to cause cancer), whether or not it has been treated.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elodie Chantalat, MD, University Hospital, Toulouse
Phone: 5.61.32.37.51
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acceptance by the patient (yes / no binary variable) of ENT and / or anal samples in addition to the cervical sample during an annual gynecological follow-up.; Number of sites sampled; Reasons for refusing multi-site samples
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.